Search





Search





Markets
/
Stocks
/
nasdaq-grml
/

Klotho Neurosciences Ord Shs

GRML

Add to Watchlist

0.391USD

+0.045+13.13%

Close 04/15, 16:00（ET）Quotes delayed by 15 min

10.60MMarket Cap

LossP/E TTM



Klotho Neurosciences Ord Shs

0.391

+0.045+13.13%

Overview Financials Analysis Company

Overview

Financials

Analysis

Company

You can check out the annual or quarterly balance sheets of Klotho Neurosciences Ord Shs here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q4

FY2025Q3

Total equity

Cash, cash equivalents and short-term investments

--7.18M

--7.35M

- Cash and cash equivalents

--7.18M

--7.35M

Receivables

----

--339.25K

-Accounts and notes receivable

----

--339.25K

Prepaid expenses

--117.07K

--86.30K

Other current assets

--0.00

----

Total current assets

--7.29M

--7.77M

Non-current assets

Goodwill and other intangible assets

--2.30M

Other non-current assets

--0.00

----

Total non-current assets

--2.30M

Total assets

--9.59M

--10.07M

Liabilities

Current liabilities

Accrued expenses

--32.16K

--57.99K

Short-term debt and lease liabilities

--0.00

----

-Short-term debt

--0.00

----

Total current liabilities

--76.76K

--92.89K

Non-current liabilities

Long-term debt and lease liabilities

--0.00

Other non-current liabilities

--53.00K

Total non-current liabilities

--53.00K

Total liabilities

--129.76K

--145.89K

Shareholders' equity

Common equity

--30.58M

--29.71M

Retained earnings

---21.11M

---19.79M

Capital reserves

--30.05M

--29.71M

Total equity

--9.46M

--9.93M

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

